The study titled "Analysis of the clinical characteristics of insulin autoimmune syndrome induced by alpha-lipoic acid" (Journal of Clinical Pharmacy and Therapeutics, 2021, PMID: 33821530) investigated 37 patients (28 females, 9 males, median age 61) who developed insulin autoimmune syndrome (IAS) after taking alpha-lipoic acid (ALA). Symptoms of hypoglycemia primarily
